<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stem Cell and Umbilical Cord Blood Information &#187; pfizer stem cell</title>
	<atom:link href="http://stemcellumbilicalcordblood.com/tag/pfizer-stem-cell/feed/" rel="self" type="application/rss+xml" />
	<link>http://stemcellumbilicalcordblood.com</link>
	<description>Umbilical Cord Blood, Stem Cell Research and Donating.</description>
	<lastBuildDate>Wed, 08 Sep 2010 15:44:22 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>Pfizer Acquires Stem-Cell Therapy From Athersys</title>
		<link>http://stemcellumbilicalcordblood.com/stem-cell-information/pfizer-acquires-stem-cell-therapy-from-athersys/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=pfizer-acquires-stem-cell-therapy-from-athersys</link>
		<comments>http://stemcellumbilicalcordblood.com/stem-cell-information/pfizer-acquires-stem-cell-therapy-from-athersys/#comments</comments>
		<pubDate>Wed, 23 Dec 2009 20:43:31 +0000</pubDate>
		<dc:creator>Sarah</dc:creator>
				<category><![CDATA[Stem Cell Information]]></category>
		<category><![CDATA[athersys pfizer]]></category>
		<category><![CDATA[pfizer stem cell]]></category>

		<guid isPermaLink="false">http://stemcellumbilicalcordblood.com/?p=490</guid>
		<description><![CDATA[Pharmaceutical giant Pfizer recently announced that it was buying the rights to a controversial cell therapy from Athersys, a biotech company. This is all part of the corporations plan to become more involved in the ever-growing interest in stem cell therapies and research. The acquisition will give Pfizer rights to develop Athersys’s cells to treat [...]]]></description>
			<content:encoded><![CDATA[<p>Pharmaceutical giant Pfizer  recently announced that it was buying the rights to a controversial cell therapy from Athersys, a biotech company. This is all part of the corporations plan to become more involved in the ever-growing interest in stem cell therapies and research. </p>
<p>The acquisition will give Pfizer rights to develop Athersys’s cells to treat inflammatory bowel disease. It will pay Athersys $6 million initially and up to $105 million in the future.</p>
<p>The relatively small payment reflects that “it’s really early for cell therapy and there’s more research to be done,” said Ruth McKernan, chief scientific officer of Pfizer Regenerative Medicine, a unit created by the company about 18 months ago to develop treatments based on stem cells. </p>
]]></content:encoded>
			<wfw:commentRss>http://stemcellumbilicalcordblood.com/stem-cell-information/pfizer-acquires-stem-cell-therapy-from-athersys/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
